Speaker:
Jan Suchodolski, MedVet, DrVetMed, PhD, AGAF, DACVM
Event date: 6–7 November 2024 Virtual Event
The gut microbiome is an immune and metabolic organ that exerts effects beyond the gastrointestinal (GI) tract, not only in health but also in disease.
Dysbiosis, an imbalance in the gut microbiota, results from changes in microbial taxa populations and/or diversity which, in turn, produces a functional shift in the microbiome. The fecal dysbiosis index reflects microbiota shifts, making it a useful tool in staging intestinal changes in chronic enteropathy cases.
In this presentation, Dr. Suchodolski discusses how dysbiosis patterns vary across GI diseases and reviews how disease, diet, antibiotics, and omeprazole can alter the gut microbiome for better or worse.
Related Content
Incorporating the Microbiome in Daily Clinical Practice-Case-Based Diagnostic and Treatment Approaches to Chronic GI Signs
Clinical cases are used to illustrate multilevel dysfunction, microbiome shifts, diagnostics and clinical staging of chronic gastrointestinal conditions in dogs. The need for multimodal management is also addressed.
Diagnosis and Clinical Interpretation of Intestinal Dysbiosis
Learn how dysbiosis is defined, how to evaluate intestinal dysbiosis using the dysbiosis index, and how to interpret the results obtained during acute and chronic conditions.
The Feline Microbiome in Gastrointestinal Disease
Real clinical cases are used to demonstrate how the intestinal microbiome impacts development of common GI disorders in cats and how to manage intestinal dysbiosis.
Part of the whole: the role of the gut microbiome in host health
Learn how the gut microbiome is a metabolic and immunologic organ that plays an important role in health and disease. Dr. Suchodolski also explores the relationship between the microbiota, dysbiosis and systemic organ disease.